Y200-1486 Screening compound: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-morpholinoacetamide

Y200-1486 Screening compound: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-morpholinoacetamide
Y200-1486 Screening compound: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-morpholinoacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-1486
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-morpholinoacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-1486

Molecular Formula

C15H16BrN3O2S (C15 H16 BrN3 O2 S)

Compound Name

N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-morpholinoacetamide

IUPAC name

N-[4-(4-bromophenyl)-13-thiazol-2-yl]-2-(morpholin-4-yl)acetamide

SMILES

O=C(CN1CCOCC1)Nc1nc(-c(cc2)ccc2Br)cs1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.28

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.945

Distribution Coefficient, logD

3.945

Water Solubility, LogSw

-4.06

Polar Surface Area

44.804

Acid Dissociation Constant (pKa)

11.61

Base Dissociation Constant (pKb)

4.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.33

Y200-1486 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y200-1486 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-1486?
Check Price and Availability of Y200-1486, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-1486 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-1486
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-1486
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-1486 available by request